Fig 2.
(A) Blood sugar at week 4 and (B) week 8, (C) glucose total area under the curve (AUC) at week 4 and (D) week 8, (E) blood insulin at week 4, and (F) week 8, and of untreated rats (control group), streptozotocin (STZ)-treated rats (STZ group), and STZ + ProbiogluTM-treated rats (STZ + 1× ProbiogluTM group, 5.17 × 109 CFU kg-1 d-1; STZ + 5× ProbiogluTM group, 2.58 × 1010 CFU kg-1 d-1; STZ + 10× ProbiogluTM group, 5.17 × 1010 CFU kg-1 d-1). Each group consisted of 8 rats in this study. Blood sugar and insulin levels were analyzed at 0, 30, 60, 90, 120, 180 min after the administration of high-dose glucose (1 g kg-1).* indicates significant differences compared with the control at p < 0.05.